TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Physiologic measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observer ratings of effects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive/performance measures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Development of autistic children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Tube Success at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food intake during buffet meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean difference of cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in steps per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful fracture union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing Disturbance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to First Analgesic Request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Amount of Postoperative Pain Medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Intensity assessed by the Visual Analog Scale (VIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in MDS-UPDRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in hair density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of death excluding disease-related death
Endpoint domain: Mortality/survival
Primary endpoint: Sputum microbiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Exercise Endurance Time to Maximum Tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Survival in Lymph Nodes Examined Patients
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival in Bone Marrow Examined Patients
Endpoint domain: Mortality/survival
Primary endpoint: Severity of labor pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of periodic limb movements while in bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change From Baseline in Square Root GA Lesion Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of surgical failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: V max
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: bladder compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: percent change in Binding Potential (BPND)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional measurements of change in child's abilities with arms and hands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Existence of drug interaction
Endpoint domain: Adverse events/effects
Primary endpoint: Health Care Workers absenteeism
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Efficiency of preoxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete aneurysm occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Occurrence of ipsilateral major stroke or neurovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Change of functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Overall compliance to the ERAS program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Preterm birth < 34 gestational weeks
Endpoint domain: Mortality/survival
Primary endpoint: accuracy of orbital volume reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NIH-EXAMINER Executive Composite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean blood pressure more than or equal 65mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lactate clearance to be 2mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD-RS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Incidence of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Reproducibility of Brain Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overall Reproducibility of Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity and Specificity for Lesion Detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: plantar pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: daily life disturbance scales
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum plasma concentration (Cmax) of SHR0302
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC) of SHR0302
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Pathologic Complete Response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Nutritional intakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effort of alternatives
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Concentration of caffeine in vitreous probes and epiretinal membranes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of cystocele
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Neuropsychological Test Battery in Total Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Skin temperature change over big toe
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Informed choice about cataract surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in autonomic function (pulse)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in autonomic function (blood pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in autonomic function (temperature)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain reduction in VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rey Auditory Verbal Learning Test (RAVLT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Compliance with vaginal dilator use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Minimizing vaginal stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Switching Back to Concerta
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Changing the use of Immediate Release (IR) Methylphenidate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Starting a new Different Attention Deficit Hyperactivity Disorder (ADHD) Medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Discontinuing the use of Both Concerta and the Study Drug to Which the Participant is Switched
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sustained Viral Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary Patency rate at 12-months post-op
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of serious device-related adverse events within 30 days post-op
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetic equivalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of ovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Severity of Obstructive Sleep Apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Variability in transcutaneous volume-averaged thoracic bio-conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with device-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Total Number of Steps Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total body fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change From Baseline in Size (Area) of Secondary Hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical Attachment Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Janus-kinase 3 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: highest dose of stereotactic radiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sum of Pain Intensity Difference (SPID) at Hour 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of further assessment of abnormal tests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in AP lumbar spine bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thromboembolism/Thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Hemorrhage/Bleeding-Anticoagulant/Antiaggregant (All and Major)
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness Endpoint - NYHA Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Experiencing Acute, Late Skin, and Subcutaneous Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the curve of Glucose for the entire experiment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Curve for Plasma osmolality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Rejection
Endpoint domain: Adverse events/effects
Primary endpoint: number of new T2 lesions on brain MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor evoked potentials change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in level of EORTC QLQ-C15-PAL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Withdrawal severity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Cerebral Blood Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in TBI Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cognitive Functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cataloging bacteria and micro-organisms on the eye surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Heart Rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative Sore Throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measure of stress with DASS-42
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of Family Hypercholesterolemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shoulder pain and disability index (SPADI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AUC0-24h of risperidone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening HF symptoms or HF-related clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Satiety Hunger Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correlation of POCUS measurements with AHI and/or STOP-Bang Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as measured by adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose as measured by dose limiting toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to Recurrence of Mood Event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe Acute GVHD-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: AMI Composite Quality Indicator
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CHF Composite Quality Indicator
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean daily crying duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erectile Function as measured by IIEF-EF
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Cerebrovascular Ischemia, major Hemorrhagic events or Death (CIHD)
Endpoint domain: Mortality/survival
Primary endpoint: Change in Waist Circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean metabolic equivalent minutes of physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diet Quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Depth or grade of endoscopic remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Donor Engraftment (Chimerism)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Grades III-IV Acute GVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Non-relapse-related Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from severe or unanticipated device related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients scoring ≥ 8 in GERD-Q
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Graft take up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from Baseline in weight-for-age Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of preoperative anaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants Achieving 90% Improvement in Psoriasis Area and Severity Index (PASI90)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of endometriosis associated pelvic pain (EAPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of Atomic Magnetometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores on the Asthma Action Plan Knowledge Interview
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Resolution of Stress urinary Incontinence (questionnaire)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of Stress urinary Incontinence (Urodynamic Studies)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of Stress urinary Incontinence (pad count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of Stress urinary Incontinence (cough stress test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Serum Phosphorus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time from presentation to treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain Intercept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sexual risk behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in phosphorylation of intracellular target proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in mRNA expression of target genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Eradication rate of H.pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: All-cause Hospitalization or Emergency Department Visit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Morphia dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline serum alanine aminotransferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of Vascularization index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: peak knee flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Dose response effectiveness of Recombinant Factor VIIa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Treatment Success (6 or Fewer Hospitalizations During Front-line Chemotherapy)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Difference in TRODAT binding to DAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overall Radiographic Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of malignant adnexal masses detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in FDG avidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of common complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in diffusion tensor imaging measures over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain atrophy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in levels of fluid biomarkers in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in levels of fluid biomarkers in cerebral fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline level of discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of pathological complete remissions (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Response to Rabbit Antithymocyte Globulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating exposure (AUC) to amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circulating exposure (AUC) to atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circulating exposure (AUC) to rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: average painful intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Oswestry Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Satisfaction with Smokefree TXT Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usage of Smokefree TXT Program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants with at least one Treatment-Emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Functional brain imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes